{"id":11316,"date":"2024-12-02T07:29:17","date_gmt":"2024-12-02T07:29:17","guid":{"rendered":"https:\/\/jubilantbiosys.com\/new-staging\/?page_id=11316"},"modified":"2025-01-30T06:12:13","modified_gmt":"2025-01-30T06:12:13","slug":"rna-small-molecule-drugs","status":"publish","type":"page","link":"https:\/\/www.jubilantbiosys.com\/new-staging\/target-approaches\/rna-small-molecule-drugs\/","title":{"rendered":"RNA Small Molecule Drugs"},"content":{"rendered":"\n<div class=\"wp-block-group health-safety-left-col-main\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group solutions-details-head is-nowrap is-layout-flex wp-container-core-group-is-layout-8f761849 wp-block-group-is-layout-flex\">\n<h2 class=\"wp-block-heading\">RNA small molecule drugs<\/h2>\n<\/div>\n\n\n\n<div class=\"wp-block-group solutions-details-content\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"wp-block-paragraph\">The recognition that RNAs play roles beyond coding for proteins, influencing disease states, has unveiled a plethora of uncharted therapeutic targets. The discrete secondary and tertiary structures adopted by many RNAs fulfill essential biological functions and present unique pockets and grooves suitable for small molecule binding. Additionally, the inhibition of translation and the deactivation of noncoding RNA structures are mechanisms through which RNA-targeted small molecules can combat disease. These new realizations have spurred a surge in interest to develop small molecules that can selectively target these structured RNAs, potentially leading to treatments for conditions that have eluded traditional drug discovery approaches.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Jubilant Biosys services include development of custom-tailored screening platform that includes high-throughput screening and structure-activity relationship (SAR) support. We can support our clients in development and application of multiple approaches to study RNA \u2013 small molecule interaction and the dependent phenotypic outcome.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group our-principles-col mt-0\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group solutions-details-content\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group solutions-details-content-tow-col-inner\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<ul class=\"wp-block-list\">\n<li>Affinity selection mass spectrometry (ASMS).<\/li>\n\n\n\n<li>Fluorescence based assay (Intrinsic fluorescence &amp; fluorophore labeled RNA).<\/li>\n\n\n\n<li>RNA-protein interaction inhibitor screening (HTRF).<\/li>\n\n\n\n<li>RNA target dependent biomarker assays (qPCR &amp; Western blotting).<\/li>\n\n\n\n<li>Bioluminescent Reporter assay (Luminescence).<\/li>\n\n\n\n<li>Custom made phenotypic assays based on target biology.<\/li>\n<\/ul>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group solutions-details-content-tow-col-inner mt-4\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"wp-block-paragraph\">Jubilan Biosys can support client projects involving RNA small molecule drug discovery at all stages of preclinical development ranging from hit finding to preclinical candidate nomination.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RNA small molecule drugs The recognition that RNAs play roles beyond coding for proteins, influencing disease states, has unveiled a plethora of uncharted therapeutic targets. The discrete secondary and tertiary structures adopted by many RNAs fulfill essential biological functions and present unique pockets and grooves suitable for small molecule binding. Additionally, the inhibition of translation [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":11117,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-target-approaches.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-11316","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RNA Small Molecule Drugs | Jubilant Biosys<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RNA Small Molecule Drugs | Jubilant Biosys\" \/>\n<meta property=\"og:description\" content=\"RNA small molecule drugs The recognition that RNAs play roles beyond coding for proteins, influencing disease states, has unveiled a plethora of uncharted therapeutic targets. The discrete secondary and tertiary structures adopted by many RNAs fulfill essential biological functions and present unique pockets and grooves suitable for small molecule binding. Additionally, the inhibition of translation [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"Jubilant Biosys\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-30T06:12:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/target-approaches\\\/rna-small-molecule-drugs\\\/\",\"url\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/target-approaches\\\/rna-small-molecule-drugs\\\/\",\"name\":\"RNA Small Molecule Drugs | Jubilant Biosys\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/#website\"},\"datePublished\":\"2024-12-02T07:29:17+00:00\",\"dateModified\":\"2025-01-30T06:12:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/target-approaches\\\/rna-small-molecule-drugs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.jubilantbiosys.com\\\/target-approaches\\\/rna-small-molecule-drugs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/target-approaches\\\/rna-small-molecule-drugs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Target Approaches\",\"item\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/target-approaches\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"RNA Small Molecule Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/#website\",\"url\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/\",\"name\":\"Jubilant Biosys\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/#organization\",\"name\":\"Jubilant Biosys\",\"url\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/new-staging\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/jbl-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/new-staging\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/jbl-logo.png\",\"width\":169,\"height\":132,\"caption\":\"Jubilant Biosys\"},\"image\":{\"@id\":\"https:\\\/\\\/www.jubilantbiosys.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RNA Small Molecule Drugs | Jubilant Biosys","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/","og_locale":"en_US","og_type":"article","og_title":"RNA Small Molecule Drugs | Jubilant Biosys","og_description":"RNA small molecule drugs The recognition that RNAs play roles beyond coding for proteins, influencing disease states, has unveiled a plethora of uncharted therapeutic targets. The discrete secondary and tertiary structures adopted by many RNAs fulfill essential biological functions and present unique pockets and grooves suitable for small molecule binding. Additionally, the inhibition of translation [&hellip;]","og_url":"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/","og_site_name":"Jubilant Biosys","article_modified_time":"2025-01-30T06:12:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/","url":"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/","name":"RNA Small Molecule Drugs | Jubilant Biosys","isPartOf":{"@id":"https:\/\/www.jubilantbiosys.com\/#website"},"datePublished":"2024-12-02T07:29:17+00:00","dateModified":"2025-01-30T06:12:13+00:00","breadcrumb":{"@id":"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.jubilantbiosys.com\/target-approaches\/rna-small-molecule-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.jubilantbiosys.com\/"},{"@type":"ListItem","position":2,"name":"Target Approaches","item":"https:\/\/www.jubilantbiosys.com\/target-approaches\/"},{"@type":"ListItem","position":3,"name":"RNA Small Molecule Drugs"}]},{"@type":"WebSite","@id":"https:\/\/www.jubilantbiosys.com\/#website","url":"https:\/\/www.jubilantbiosys.com\/","name":"Jubilant Biosys","description":"","publisher":{"@id":"https:\/\/www.jubilantbiosys.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.jubilantbiosys.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.jubilantbiosys.com\/#organization","name":"Jubilant Biosys","url":"https:\/\/www.jubilantbiosys.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.jubilantbiosys.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-content\/uploads\/2024\/10\/jbl-logo.png","contentUrl":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-content\/uploads\/2024\/10\/jbl-logo.png","width":169,"height":132,"caption":"Jubilant Biosys"},"image":{"@id":"https:\/\/www.jubilantbiosys.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/pages\/11316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/comments?post=11316"}],"version-history":[{"count":7,"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/pages\/11316\/revisions"}],"predecessor-version":[{"id":13751,"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/pages\/11316\/revisions\/13751"}],"up":[{"embeddable":true,"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/pages\/11117"}],"wp:attachment":[{"href":"https:\/\/www.jubilantbiosys.com\/new-staging\/wp-json\/wp\/v2\/media?parent=11316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}